AAAAAA

   
Results: 1-17 |
Results: 17
The melanocortin-1-receptor gene is the major freckle gene
Authors: Bastiaens, M ter Huurne, J Gruis, N Bergman, W Westendorp, R Vermeer, BJ Bavinck, JNB
Citation: M. Bastiaens et al., The melanocortin-1-receptor gene is the major freckle gene, HUM MOL GEN, 10(16), 2001, pp. 1701-1708
Multiple primary melanomas
Authors: Stam-Posthuma, JJ van Duinen, C Scheffer, E Vink, J Bergman, W
Citation: Jj. Stam-posthuma et al., Multiple primary melanomas, J AM ACAD D, 44(1), 2001, pp. 22-27
Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color
Authors: Kennedy, C ter Huurne, J Berkhout, M Gruis, N Bastiaens, M Bergman, W Willemze, R Bavinck, JNB
Citation: C. Kennedy et al., Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color, J INVES DER, 117(2), 2001, pp. 294-300
Promoter hypermethylation: A common cause of reduced p16(INK4a) expressionin uveal melanoma
Authors: van der Velden, PA Metzelaar-Blok, JAW Bergman, W Hurks, HMH Frants, RR Gruis, NA Jager, MJ
Citation: Pa. Van Der Velden et al., Promoter hypermethylation: A common cause of reduced p16(INK4a) expressionin uveal melanoma, CANCER RES, 61(13), 2001, pp. 5303-5306
Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma
Authors: van der Velden, PA Sandkuijl, LA Bergman, W Pavel, S van Mourik, L Frants, RR Gruis, NA
Citation: Pa. Van Der Velden et al., Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma, AM J HU GEN, 69(4), 2001, pp. 774-779
High interleukin-10 production in first-degree relatives of patients with generalized but not cutaneous lupus erythematosus
Authors: van der Linden, MW Westendorp, RGJ Sturk, A Bergman, W Huizinga, TWJ
Citation: Mw. Van Der Linden et al., High interleukin-10 production in first-degree relatives of patients with generalized but not cutaneous lupus erythematosus, J INVES MED, 48(5), 2000, pp. 327-334
Cutaneous malignant melanoma: clinical aspects, imaging modalities and treatment
Authors: Ak, I Stokkel, MPM Bergman, W Pauwels, EKJ
Citation: I. Ak et al., Cutaneous malignant melanoma: clinical aspects, imaging modalities and treatment, EUR J NUCL, 27(4), 2000, pp. 347-358
Double-blind, placebo-controlled study of oral calcitriol for the treatment of localized and systemic scleroderma
Authors: Hulshof, MM Bavinck, JNB Bergman, W Masclee, AAM Heickendorff, L Breedveld, FC Dijkmans, BAC
Citation: Mm. Hulshof et al., Double-blind, placebo-controlled study of oral calcitriol for the treatment of localized and systemic scleroderma, J AM ACAD D, 43(6), 2000, pp. 1017-1023
Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden)
Authors: Vasen, HFA Gruis, NA Frants, RR van der Velden, PA Hille, ETM Bergman, W
Citation: Hfa. Vasen et al., Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden), INT J CANC, 87(6), 2000, pp. 809-811
Patients' illness perceptions and coping as predictors of functional status in psoriasis: a 1-year follow-up
Authors: Scharloo, M Kaptein, AA Weinman, J Bergman, W Vermeer, BJ Rooijmans, HGM
Citation: M. Scharloo et al., Patients' illness perceptions and coping as predictors of functional status in psoriasis: a 1-year follow-up, BR J DERM, 142(5), 2000, pp. 899-907
Teaching non-specialist health care professionals how to identify the atypical mole syndrome phenotype: a multinational study
Authors: Bishop, JAN Bradburn, M Bergman, W Osterlind, A Pinney, E Rosdahl, I Scerri, L Weichenthal, M Mant, D Breitbart, EW Karlsson, P Altman, DG
Citation: Jan. Bishop et al., Teaching non-specialist health care professionals how to identify the atypical mole syndrome phenotype: a multinational study, BR J DERM, 142(2), 2000, pp. 331-337
A locus linked to p16 modifies melanoma risk in Dutch familial atypical multiple mole melanoma (FAMMM) syndrome families
Authors: van der Velden, PA Sandkuijl, LA Bergman, W Hille, ETM Frants, RR Gruis, NA
Citation: Pa. Van Der Velden et al., A locus linked to p16 modifies melanoma risk in Dutch familial atypical multiple mole melanoma (FAMMM) syndrome families, GENOME RES, 9(6), 1999, pp. 575-580
Familial melanoma; CDKN2A and beyond
Authors: Gruis, NA van der Velden, PA Bergman, W Frants, RR
Citation: Na. Gruis et al., Familial melanoma; CDKN2A and beyond, J INV D SYM, 4(1), 1999, pp. 50-54
Consensus on the management of malignant melanoma of the skin in the Netherlands
Authors: Kroon, BBR Bergman, W Coebergh, JWW Ruiter, DJ
Citation: Bbr. Kroon et al., Consensus on the management of malignant melanoma of the skin in the Netherlands, MELANOMA RE, 9(3), 1999, pp. 207-212
Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: A consensus statement of the melanoma genetics consortium
Authors: Kefford, RF Bishop, JAN Bergman, W Tucker, MA
Citation: Rf. Kefford et al., Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: A consensus statement of the melanoma genetics consortium, J CL ONCOL, 17(10), 1999, pp. 3245-3251
Risk of cutaneous malignant melanoma in patients with nonfamilial atypicalnevi from a pigmented lesions clinic
Authors: Snels, DGCTM Hille, ETM Gruis, NA Bergman, W
Citation: Dgctm. Snels et al., Risk of cutaneous malignant melanoma in patients with nonfamilial atypicalnevi from a pigmented lesions clinic, J AM ACAD D, 40(5), 1999, pp. 686-693
Effect of topical tretinoin under occlusion on atypical naevi
Authors: Stam-Posthuma, JJ Vink, J le Cessie, S Bruijn, JA Bergman, W Pavel, S
Citation: Jj. Stam-posthuma et al., Effect of topical tretinoin under occlusion on atypical naevi, MELANOMA RE, 8(6), 1998, pp. 539-548
Risultati: 1-17 |